NCT01515202View on ClinicalTrials.gov

Japanese Phase 1 Multiple Ascending Dose Study

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

BMS-823778

Capsules, Oral, 2 mg, Once daily, 14 days

DRUG

BMS-823778

Capsules, Oral, 12 mg, Once daily, 14 days

DRUG

BMS-823778

Capsules, Oral, 25 mg, Once daily, 14 days

DRUG

BMS-823778

Capsules, Oral, 15 mg, Once daily, 14 days

DRUG

Placebo matching with BMS-823778

Capsules, Oral, 0 mg, Once daily, 14 days

Trial Locations (1)

1920071

Local Institution, Hachioji-Shi

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY